BPG is committed to discovery and dissemination of knowledge
Observational Study
©The Author(s) 2021.
World J Hepatol. Jan 27, 2021; 13(1): 132-143
Published online Jan 27, 2021. doi: 10.4254/wjh.v13.i1.132
Table 1 Baseline characteristics reported as n (%) or mean (SD)
Variable
Overall cohort (n = 91)
Age51 (12.1)
Sex (male)68 (74.7)
Presenting symptom
Jaundice21 (23.1)
Fever11 (12.1)
Abdominal pain14 (15.4)
Asymptomatic21 (25)
Liver biopsy performed first51 (56)
Percutaneous liver biopsy65 (71.4)
Bile duct diameter (mm)4.6 (1.9)
R factor2 (2.4), Range: 0.1-6.4
Alkaline phosphatase (international units/liter)392.6 (248.4)
AST (units/liter)200.5 (674.8)
ALT (units/liter)205.4 (444.2)
Total bilirubin (mg/dL)4.5 (5.4)
Deceased donor73 (80.2)
Transplant biliary anatomy
Duct-to-duct67 (73.6)
Roux-en-Y hepaticojejunostomy24 (26.4)
Tacrolimus66 (73.3)
Sirolimus20 (22.2)
Everolimus6 (6.6)
Mycophenolate sodium28 (31.1)
Mycophenolate mofetil13 (14.4)
Cyclosporine16 (17.8)
Prednisone20 (22.2)
Immunosuppression monotherapy20 (22)
Dual immunosuppression therapy68 (74.7)
Triple immunosuppression therapy3 (3.3)


Write to the Help Desk